Acadia Pharmaceuticals | ACAD - Stock


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Acadia Pharmaceuticals

Acadia Pharmaceuticals reported $6.1M in Stock for its fiscal quarter ending in March of 2023.


Stock Change
Acadia Pharmaceuticals ACAD:US USD 6.1M 541K
Alnylam Pharmaceuticals ALNY:US USD 131.88M 2.92M
Biogen BIIB:US USD 1.28B 63.4M
Corcept Therapeutics CORT:US USD 6.41M 309K
Eisai 4523:JP JPY 140.42B 19.55B
Incyte Corp INCY:US USD 40.88M 80.08M
Intercept Pharmaceuticals ICPT:US USD 6.46M 1000
Intra Cellular Therapies ITCI:US USD 28.34M 4.42M
J&J JNJ:US USD 12.81B 326M
Marinus Pharmaceuticals MRNS:US USD 37K 40K
Moderna Inc MRNA:US USD 732M 217M
Neurocrine Biosciences NBIX:US USD 33.4M 1.7M
Sarepta Therapeutics SRPT:US USD 202.68M 1.29M
Seattle Genetics SGEN:US USD 477.69M 50.48M
Ultragenyx Pharmaceutical RARE:US USD 26.62M 150K
Vertex Pharmaceuticals VRTX:US USD 535.1M 74.5M